American association for the study of liver diseases endpoints conference: Design and endpoints for clinical trials in primary biliary cirrhosis


  • Potential conflict of interest: Dr. M. Silveira is the recipient of the 2009 AASLD Advanced/Transplant Hepatology Fellowship Award, Dr. E. Brunt has no disclosures, Dr. J. Heathcote has received grant funding (both restricted and unrestricted) from Axcan Pharma and Intercept Pharma, Dr. G. Gores has no disclosures, Dr. K. Lindor has received research support from Axcan Pharma and Intercept Pharma, and Dr. M. Mayo has received restricted grant funding from Intercept Pharma.